Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 78

Sort by

Sort Order Select

Journal Articles

Digital AI in Hematology - Integration of the Scopio Labs x100 Scanner with Newly Implemented AI Capabilities into Routine Clinical Workflow

Christian Salib, Swati Bhardwaj, Shafinaz Hussein, Siraj El Jamal, Bruce Petersen, Eileen Scigliano, Francine R. Dembitzer, Julie Teruya-Feldstein

Blood (2021) 138 (Supplement 1): 4932.

https://doi.org/10.1182/blood-2021-148821

Published: 2021

Journal Articles

Aberrant Cell Cycle Programming Confers Rapid Lethality in the EuSOX11+ CCND1 MCL Mouse Model

Donna R Edwards, MPH, PhD, Pei-yu Kuo, MS, Alessandro Lagana, PhD, Seongjee Park, Pavithra Nedumaran, MS, Violetta Leshchenko, PhD, Stephanie Christie, PhD, Shashidhar Jatiani, PhD, Julie Teruya-Feldstein, MD, Samir Parekh, MD

Blood (2020) 136 (Supplement 1): 6–7.

https://doi.org/10.1182/blood-2020-143038

Published: 2020

Journal Articles

Atypical Peripheral Blood Cell Morphology in COVID-19 (Sars-CoV-2) Patients from Mount Sinai Health System in New York City

Christian Salib, MD, Pallavi Khattar, MD, Jinjun Cheng, Julie Teruya-Feldstein, MD

Blood (2020) 136 (Supplement 1): 26–27.

https://doi.org/10.1182/blood-2020-142581

Published: 2020

Journal Articles

Hypersegmented granulocytes and COVID-19 infection

Christian Salib, Julie Teruya-Feldstein

Blood (2020) 135 (24): 2196.

https://doi.org/10.1182/blood.2020006483

Published: 2020

Journal Articles

Immune dysregulation: EBV + DLBCL and HLH in a patient with T-LGL

Yougen Zhan, Julie Teruya-Feldstein

Blood (2019) 133 (15): 1695.

https://doi.org/10.1182/blood-2019-01-899484

Published: 2019

Journal Articles

Isogenic iPSC Models of SRSF2 -Mutant Myelodysplastic Syndrome Capture Disease Phenotypes, Splicing Defects and Drug Responses

Chan-Jung Chang, PhD, Andriana Kotini, PhD, Julie Teruya-Feldstein, MD, Omar Abdel-Wahab, MD, Robert Bradley, PhD, Eirini P. Papapetrou, MD PhD

Blood (2016) 128 (22): 962.

https://doi.org/10.1182/blood.V128.22.962.962

Published: 2016

Journal Articles

Targeting the Osteoblast in Myelodysplasia and Acute Myeloid Leukemia

Masahiro Marshall Nakagawa, Aruna Kode, Sanil J Manavalan, Govind Bhagat, MD, Julie Teruya-Feldstein, MD, Azra Raza, MD, Ellin Berman, MD, Stavroula Kousteni

Blood (2015) 126 (23): 2551.

https://doi.org/10.1182/blood.V126.23.2551.2551

Published: 2015

Journal Articles

Tumor-specific HSP90 inhibition as a therapeutic approach in JAK-mutant acute lymphoblastic leukemias

Blood (2015) 126 (22): 2479–2483.

https://doi.org/10.1182/blood-2015-03-635821

Published: 2015

Includes: Supplemental data

Journal Articles

Genomic Profiling Combining DNA and RNA Analysis of 112 Formalin-Fixed Paraffin-Embedded Diffuse Large B Cell Lymphoma Specimens Identifies a High Frequency of Clinically Relevant Genomic Alterations

Blood (2014) 124 (21): 704.

https://doi.org/10.1182/blood.V124.21.704.704

Published: 2014

Journal Articles

Genetic Mechanisms of Immune Escape in Diffuse Large B Cell Lymphoma

Marco Fangazio, MD PhD, David Dominguez-Sola, MD PhD, Fabrizio Tabbò, MD, Davide Rossi, MD PhD, Julie Teruya-Feldstein, MD, Renzo Boldorini, MD, Gianluca Gaidano, MD PhD, Govind Bhagat, MD, Giorgio Inghirami, MD, Laura Pasqualucci, MD, Riccardo Dalla-Favera, MD

Blood (2014) 124 (21): 1692.

https://doi.org/10.1182/blood.V124.21.1692.1692

Published: 2014

Journal Articles

Bone Marrow Core Biopsy Adequacy and Variability in the United Stated and Canada: A Multicenter Retrospective Study

Mihai Merzianu, MD, Richard Cheney, MD, Adrienne Groman, MS, George Deeb, MD, Gregory Wilding, PhD, Claudiu Cotta, MD, Ramila Amre, MD, Manjula Balasubramanian, MD, Guilherme Brandao, MD, Russell K. Brynes, MD, Sindhu Cherian, MD, Elizabeth Courville, MD, David Czuchlewski, MD, Guang Fan, MD PhD, David Grier, MD, Daniela Hoehn, MD PhD, Robert E Hutchison, MD, Kedar V. Inamdar, MD PhD, Ridas Juskevicius, MD, Prabhjot Kaur, MD, John Lazarchick, MD, Michael R Lewis, MD, Rodney R. Miles, MD PhD, Jerome B. Myers, MD PhD, Michel Nasr, MD, Hina Naushad, MD, Horatiu Olteanu, MD PhD, Attilio Orazi, MD, Vishnu VB Reddy, MD, Valentin G Robu, MD, Gratian Salaru, MD, Julie Teruya-Feldstein, MD, Neerja Vajpayee, MD, Jeffrey Vos, MD, Ling Zhang, MD, Shanxing Zhang, MD PhD, Ashley V Sedelmeyer, MHA, Vivian Arguello, MD, Le Aye, DO, Sharon Barouk, MA, Elisa F Brega, MD PhD, Richie Carpenter, BS, James E. Coad, MD, Alana DiPonio, MT, Fernandez Garcia, MS, MD, John Grantham, BS, Sinisa Ivelja, MD, Robert McKenna, MD, Kieran Sultan, MD, Matthew B Thomsen, MPH, Jie Xu, MD PhD, LoAnn Peterson, MD, Vishala T. Neppalli, MD

Blood (2014) 124 (21): 1316.

https://doi.org/10.1182/blood.V124.21.1316.1316

Published: 2014

Journal Articles

Foxo1 Expressed in Osteoblasts Promotes the Leukemogenic Properties of β-Catenin By Activating Notch Signaling

Aruna Kode, Ioanna Mosialou, Sanil J Manavalan, Julie Teruya Feldstein, Govind Bhagat, MD, Ellin Berman, MD, Stavroula Kousteni

Blood (2014) 124 (21): 2356.

https://doi.org/10.1182/blood.V124.21.2356.2356

Published: 2014

Journal Articles

Conditional Loss of Dnmt3a Results in Myeloproliferation and Liver-Specific Myeloid Expansion

Olga A Guryanova, MD PhD, Yen Lieu, PhD, Kaitlyn R Shank, B.S., Sharon Rivera, PhD, Francine E Garrett-Bakelman, MD PhD, Jacob Glass, MD PhD, Matthew D Keller, B.S., Suveg Pandey, B.S., Daniel Tovbin, Abby R Weinstein, Julie Teruya-Feldstein, MD, Omar Abdel-Wahab, MD, Christopher E Mason, PhD, Ari M Melnick, MD, Siddhartha Mukherjee, MD PhD, Ross L. Levine, MD

Blood (2014) 124 (21): 364.

https://doi.org/10.1182/blood.V124.21.364.364

Published: 2014

Journal Articles

Inhibition of leukemia cell engraftment and disease progression in mice by osteoblasts

Blood (2014) 124 (18): 2834–2846.

https://doi.org/10.1182/blood-2013-07-517219

Published: 2014

Includes: Supplemental data

Journal Articles

A targeted mutational landscape of angioimmunoblastic T-cell lymphoma

Blood (2014) 123 (9): 1293–1296.

https://doi.org/10.1182/blood-2013-10-531509

Published: 2014

Includes: Supplemental data

Journal Articles

Phase II Trial Of The BRAF Inhibitor, Vemurafenib, In Patients With BRAF Mutant Relapsed Or Refractory Hairy Cell Leukemia

Jae H Park, MD, Stephen S. Chung, MD, Young Rock Chung, MSc, Helen Won, MS, Julie Teruya-Feldstein, MD, Michael Berger, PhD, Talal T Khawaja, BS, Mario E Lacouture, MD, Ross L. Levine, MD, Omar Abdel-Wahab, MD, Martin S Tallman, MD

Blood (2013) 122 (21): 2876.

https://doi.org/10.1182/blood.V122.21.2876.2876

Published: 2013

Journal Articles

Cross-Platform Assessment Of Genomic Imbalance In Diffuse Large B-Cell Lymphoma Identifies Novel Candidate Loci and Genes With Prognostic Value and Roles In Lymphomagenesis

Lizalynn Dias, Ph.D., Venkata Thodima, Ph.D., Geetu Mendiratta, Ph.D., Guttapalli Asha, M.S., Camille Gonzalez, Jocelyn C. Maragulia, Andrew D. Zelenetz, MD, PhD, Julie Teruya Feldstein, MD, Raju S.K. Chaganti, PhD, FACMG, Jane Houldsworth, PhD

Blood (2013) 122 (21): 4259.

https://doi.org/10.1182/blood.V122.21.4259.4259

Published: 2013

Journal Articles

Profiling Genomic Alterations Of Diffuse Large B-Cell Lymphoma (DLBCL) At Diagnosis, Relapse, and Transformation, Using a Novel Clinical Diagnostic Targeted Sequencing Platform

Blood (2013) 122 (21): 1761.

https://doi.org/10.1182/blood.V122.21.1761.1761

Published: 2013

Journal Articles

Next-Generation Sequencing Suggests Complex, Heterogeneous Pathogenesis In Peripheral T-Cell Lymphoma Unspecified

Jonathan H. Schatz, MD, Steven M. Horwitz, MD, Matthew A. Lunning, DO, Igor Dolgalev, Kety Huberman, Adriana Heguy, Agnes Viale, PhD, Nicholas D. Socci, Mono Pirun, Julie Teruya-Feldstein, MD, Hans-Guido Wendel, MD

Blood (2013) 122 (21): 843.

https://doi.org/10.1182/blood.V122.21.843.843

Published: 2013

Journal Articles

BRAF V600E Mutations Occur In The Hematopoietic Stem Cell Compartment In Hairy Cell Leukemia

Stephen S. Chung, MD, Jae H. Park, MD, Eunhee Kim, PhD, Young Rock Chung, MSc, Wenhuo Hu, PhD, Piro Lito, MD, PhD, Julie Teruya Feldstein, MD, Raajit K. Rampal, M.D., Ph.D., Leon Telis, Minal Patel, Neal Rosen, Christopher Y. Park, M.D., Ph.D., Martin S. Tallman, MD, Omar Abdel-Wahab, MD

Blood (2013) 122 (21): 816.

https://doi.org/10.1182/blood.V122.21.816.816

Published: 2013

NARROW

Digital AI in Hematology - Integration of the Scopio Labs x100 Scanner with Newly Implemented AI Capabilities into Routine Clinical Workflow

Aberrant Cell Cycle Programming Confers Rapid Lethality in the EuSOX11+ CCND1 MCL Mouse Model

Atypical Peripheral Blood Cell Morphology in COVID-19 (Sars-CoV-2) Patients from Mount Sinai Health System in New York City

Hypersegmented granulocytes and COVID-19 infection

Immune dysregulation: EBV + DLBCL and HLH in a patient with T-LGL

Isogenic iPSC Models of SRSF2 -Mutant Myelodysplastic Syndrome Capture Disease Phenotypes, Splicing Defects and Drug Responses

Targeting the Osteoblast in Myelodysplasia and Acute Myeloid Leukemia

Tumor-specific HSP90 inhibition as a therapeutic approach in JAK-mutant acute lymphoblastic leukemias

Genomic Profiling Combining DNA and RNA Analysis of 112 Formalin-Fixed Paraffin-Embedded Diffuse Large B Cell Lymphoma Specimens Identifies a High Frequency of Clinically Relevant Genomic Alterations

Genetic Mechanisms of Immune Escape in Diffuse Large B Cell Lymphoma

Bone Marrow Core Biopsy Adequacy and Variability in the United Stated and Canada: A Multicenter Retrospective Study

Foxo1 Expressed in Osteoblasts Promotes the Leukemogenic Properties of β-Catenin By Activating Notch Signaling

Conditional Loss of Dnmt3a Results in Myeloproliferation and Liver-Specific Myeloid Expansion

Inhibition of leukemia cell engraftment and disease progression in mice by osteoblasts

A targeted mutational landscape of angioimmunoblastic T-cell lymphoma

Phase II Trial Of The BRAF Inhibitor, Vemurafenib, In Patients With BRAF Mutant Relapsed Or Refractory Hairy Cell Leukemia

Cross-Platform Assessment Of Genomic Imbalance In Diffuse Large B-Cell Lymphoma Identifies Novel Candidate Loci and Genes With Prognostic Value and Roles In Lymphomagenesis

Profiling Genomic Alterations Of Diffuse Large B-Cell Lymphoma (DLBCL) At Diagnosis, Relapse, and Transformation, Using a Novel Clinical Diagnostic Targeted Sequencing Platform

Next-Generation Sequencing Suggests Complex, Heterogeneous Pathogenesis In Peripheral T-Cell Lymphoma Unspecified

BRAF V600E Mutations Occur In The Hematopoietic Stem Cell Compartment In Hairy Cell Leukemia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only